Skip to main content
. 2020 May 18;9(8):839–849. doi: 10.1002/sctm.19-0410

TABLE 1.

Baseline characteristics of patients

Variables Intention‐to‐treat population Per‐protocol population
Vehicle (n = 19) ADSC‐CE (n = 19) P value Vehicle (n = 16) ADSC‐CE (n = 18) P value
Male 14 (73.7) 15 (78.9) .500 a 12 (75.0) 14 (77.8) .583 a
Age, years 46.21 ± 9.3 44.32 ± 8.8 .313 b 45.13 ± 9.7 43.83 ± 8.7 .489 b
Weight, cm 73.16 ± 10.6 76.61 ± 12.5 .365 b 73.24 ± 10.3 75.27 ± 11.3 .590 b
Height, cm 170.1 (163‐176) 175.9 (165‐177) .365 c 169.9 (163‐175) 171.4 (165‐177) .370 c
BMI, kg/m2 25.24 ± 3.1 25.79 ± 2.7 .555 b 25.4 ± 3.2 25.5 ± 2.4 .930 b
Alcohol drinker 3 (15.8) 4 (21.1) .500 a 2 (12.5) 4 (22.2) .389 a
Current smoker 2 (10.5) 2 (10.5) .698 a 2 (12.5) 2 (11.1) .652 a

Notes. Values are expressed as mean ± SD, median (25th‐75th percentile), or frequency (percentage). Shapiro‐Wilk's test was used to test for normality.

Abbreviations: ADSC‐CE, adipose‐derived stem cell constituent extract; BMI, body mass index.

a

P values according to Fisher's exact test.

b

P values according to independent t test.

c

P values according to Mann‐Whitney U test.